Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Assessment of visual disability using visual evoked potentials.
CC3-03: Drug Characteristics Associated with Medication Adherence Across Eight Disease States.
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma.
Any evident MRI T2-lesion activity should guide change of therapy in multiple sclerosis - Yes.
Sexual disorders in men with multiple sclerosis: Evaluation and management.
Glycerol rhizotomy and radiofrequency thermocoagulation for trigeminal neuralgia in multiple sclerosis.
Advances in Antioxidative Therapy of Multiple Sclerosis.
[How to use Japanese guidelines for the treatment of multiple sclerosis].
MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis.
HMGB1 in Development and Diseases of the Central Nervous System.
Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.
Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.
Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.
New Microparticle Secondary Progressive MS Therapy Dosing Tested In Australian Clinical Trial
Diverse functional roles of lipocalin-2 in the central nervous system.
Unmet education, psychological and peer support needs of people with multiple sclerosis.
Critical role for PDE4 subfamilies in the development of experimental autoimmune encephalomyelitis.
Self-reported health promotion and disability progression in multiple sclerosis.
Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study.
How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?-Reply.
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis.
Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.

Pages